This prospective, open-label, pilot phase 2 study examined the clinical and immunologic
effects of oregovomab (OvaRex®) in heavily pretreated patients with recurrent ovarian …

OBJECTIVES: To estimate the antitumor efficacy of dolastatin-10 in patients with measurable
recurrences of platinum-sensitive ovarian carcinoma and to determine the nature and …

Advanced epithelial ovarian cancer (AOC) is the most common clinical presentation of
ovarian cancer. Virtually all patients will require some form of chemotherapy with curative or …

OBJECTIVES.: Ovarian cancer remains a leading cause of death in women and
development of new therapies is essential. Deprivation of iron (Fe), an essential micro …

OBJECTIVE: Little performance measurement has been undertaken in the area of oncology,
particularly for surgery which is a pivotal event in the continuum of cancer care. This work …

OBJECTIVE: To evaluate the activity of oral Altretamine in women with epithelial ovarian
carcinoma who responded (PR or CR) to first line chemotherapy but relapsed within 6 …

The aim of this study was to assess the use of the MTT assay for chemosensitity testing to
identify drug resistance and predict survival in patients with advanced ovarian cancer …

Prostate cancer is one of the leading causes of cancer-related death among men. Given the
varying clinical course and the long natural history of the disease, it is important to have …

OBJECTIVES: We determined the cytotoxic effects BMS 247550 (Epo B), a derivative of
epothilone B, on cisplatinum-or paclitaxel-sensitive or-resistant human ovarian cancer cells …

We evaluated the tolerability and toxicity attributed to pegylated liposomal doxorubicin (PL‐
DOX) in women with recurrent or refractory ovarian cancer, and reviewed procedures to …